Cargando…
High Frequency of Fusion Transcripts Involving TCF7L2 in Colorectal Cancer: Novel Fusion Partner and Splice Variants
VTI1A-TCF7L2 was reported as a recurrent fusion gene in colorectal cancer (CRC), found to be expressed in three out of 97 primary cancers, and one cell line, NCI-H508, where a genomic deletion joins the two genes [1]. To investigate this fusion further, we analyzed high-throughput DNA and RNA sequen...
Autores principales: | Nome, Torfinn, Hoff, Andreas M., Bakken, Anne Cathrine, Rognum, Torleiv O., Nesbakken, Arild, Skotheim, Rolf I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946716/ https://www.ncbi.nlm.nih.gov/pubmed/24608966 http://dx.doi.org/10.1371/journal.pone.0091264 |
Ejemplares similares
-
Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival
por: Sveen, Anita, et al.
Publicado: (2011) -
Novel RNA variants in colorectal cancers
por: Hoff, Andreas M., et al.
Publicado: (2015) -
Novel transcription-induced fusion RNAs in prostate cancer
por: Zhao, Sen, et al.
Publicado: (2017) -
Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer
por: Eilertsen, Ina A., et al.
Publicado: (2018) -
Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas
por: Lind, Guro E, et al.
Publicado: (2011)